Don't Miss


Just Published
Ulcerative Colitis: KOL Insight provides detailed opinions of leading front-line clinicians on advanced treatments for UC and what they see as critical advantages/disadvantages affecting their decision to prescribe Learn more.

EMA committee backs approval of Orexigen's obesity therapy Mysimba